Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | EYA2 | O00167 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | TNF | P01375 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.32 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.32 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.32 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL73690 | 0.91 | EHMT2 (0.37) | TSHRMEN1KMT2ALMNAPOLB | |
| SCHEMBL27193333 | 0.88 | LMNA (0.37) | TSHRMEN1KMT2ALMNAEYA2 | |
| SCHEMBL28384909 | 0.84 | MEN1 (0.41) | TSHRMEN1KMT2ALMNAEYA2 | |
| SCHEMBL30392206 | 0.84 | MEN1 (0.41) | TSHRMEN1KMT2ALMNAEYA2 | |
| SCHEMBL278282 | 0.82 | GCK (0.39) | TSHRMEN1KMT2ALMNAEYA2 | |
| SCHEMBL1679370 | 0.77 | EHMT2 (0.35) | MEN1KMT2ALMNACYP1A2CYP3A4 | |
| SCHEMBL1374041 | 0.74 | GCK (0.39) | MEN1KMT2ALMNACYP1A2CYP3A4 | |
| SCHEMBL4184231 | 0.74 | MEN1 (0.37) | TSHRMEN1KMT2ALMNACYP1A2 | |
| SCHEMBL29164212 | 0.74 | KMT2A (0.38) | TSHRMEN1KMT2ALMNACYP1A2 | |
| SCHEMBL4445539 | 0.73 | NPC1 (0.36) | MEN1KMT2ALMNACYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022216734-A1 | MULTIVALENT CHOLERA MULTIEPITOPE FUSION ANTIGEN (MEFA) AND METHODS OF USE | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2022-10-13 | — | — | WO | disclosed |
| EP-3762429-A1 | DELIVERING BIOLOGICAL DRUGS TO TISSUES | University of Pittsburgh - Of the Commonwealth System of Higher Education (US) | 2021-01-13 | — | — | EP | disclosed |
| US-20200331984-A1 | HARNESSING PROTEIN-BASED DRUGS COMPRISING AN ANCHOR DOMAIN FOR USE ON THE OCULAR SURFACE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-10-22 | — | — | US | disclosed |
| WO-2019173829-A1 | DELIVERING BIOLOGICAL DRUGS TO TISSUES | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2019-09-12 | — | — | WO | disclosed |
| EP-3516063-A1 | HARNESSING PROTEIN-BASED DRUGS COMPRISING AN ANCHOR DOMAIN FOR USE ON THE OCULAR SURFACE | University of Pittsburgh- Of the Commonwealth System of Higher Education (US) | 2019-07-31 | — | — | EP | disclosed |
| WO-2018057522-A1 | HARNESSING PROTEIN-BASED DRUGS COMPRISING AN ANCHOR DOMAIN FOR USE ON THE OCULAR SURFACE | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2018-03-29 | — | — | WO | disclosed |
| US-8133680-B2 | affinity substrate comprises polydimethylsiloxane stamp alternately peptide-terminated or antibody terminated; | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-03-13 | — | — | US | disclosed |
| EP-1255996-B1 | BIOCHEMICAL BLOCKING LAYER FOR LIQUID CRYSTAL ASSAY | WISCONSIN ALUMNI RES FOUND (US) | 2010-05-26 | — | — | EP | disclosed |
| US-7651662-B2 | Rubbed substrate surfaces; activation; uniform anchoring of liquid crystals | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2010-01-26 | — | — | US | disclosed |
| EP-1668366-B1 | USING LIQUID CRYSTALS TO DETECT AFFINITY MICROCONTACT PRINTED BIOMOLECULES | WISCONSIN ALUMNI RES FOUND (US) | 2008-01-09 | — | — | EP | disclosed |
| US-6692699-B2 | RUBBED SO THAT IT DRIVES UNIFORM ANCHORING OF LIQID CRYSTALS AND BONDS THE BIOMOLECULE RECOGNITION AGENT | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2004-02-17 | — | — | US | disclosed |
| US-20030040496-A1 | Methods for halting unwanted cell growth, such as using ligand-directed nucleic acid delivery vehicles | CHANDLER LOIS ANN (US) | 2003-02-27 | — | — | US | disclosed |
| US-6503886-B1 | Gene delivery; polypeptide conjugated to fibroblast growth factor fused to nucleic acid | SELECTIVE GENETICS, INC. | 2003-01-07 | — | — | US | disclosed |
| EP-1255996-A2 | BIOCHEMICAL BLOCKING LAYER FOR LIQUID CRYSTAL ASSAY | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2002-11-13 | — | — | EP | disclosed |
| US-20020055093-A1 | Biochemical blocking layer for liquid crystal assay | NATIONAL SCIENCE FOUNDATION | 2002-05-09 | — | — | US | disclosed |
| WO-2001061325-A2 | BIOCHEMICAL BLOCKING LAYER FOR LIQUID CRYSTAL ASSAY | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2001-08-23 | — | — | WO | disclosed |
| EP-1073421-A1 | STABILIZED PROTEIN CRYSTALS, FORMULATIONS CONTAINING THEM AND METHODS OF MAKING THEM | Altus Biologics Inc. (US) | 2001-02-07 | — | — | EP | disclosed |
| WO-1999055310-A1 | STABILIZED PROTEIN CRYSTALS, FORMULATIONS CONTAINING THEM AND METHODS OF MAKING THEM | ALTUS BIOLOGICS INC. (US) | 1999-11-04 | — | — | WO | disclosed |
| EP-0833665-A1 | COMPOSITIONS CONTAINING NUCLEIC ACIDS AND LIGANDS FOR THERAPEUTIC TREATMENT | PRIZM PHARMACEUTICALS, INC. (US) | 1998-04-08 | — | — | EP | disclosed |
| WO-1996036362-A1 | COMPOSITIONS CONTAINING NUCLEIC ACIDS AND LIGANDS FOR THERAPEUTIC TREATMENT | PRIZM PHARMACEUTICALS, INC. (US) | 1996-11-21 | — | — | WO | disclosed |